Aspen Pharmacare Holdings LtdAPN:JNB

29,439
4.00 / 0.01 %
363.95k
34.13%
0.6535
Close in ZAXToday's changeShares traded1 year changeBeta
Data delayed at least 30 minutes, as of Jul 25 2014 16:49 BST.

Summary

On Friday, Aspen Pharmacare Holdings Ltd (APN:JNB) closed at 29,439, 8.57 % below its 52-week high of 32,197, set on Jun 24, 2014.

52-week range
Today
21,300
Jul 29 2013
32,197
Jun 24 2014
Markit short selling activity
Low
Medium
High
Open29,500
Day high29,640
Day low29,326
Bid29,400
Offer29,430
Previous close29,443
Average volume596.84k
Shares outstanding456.34m
Free float301.83m
P/E (TTM)35.59
Market cap134.16bn ZAR
EPS (TTM)8.26 ZAR
Annual div (TTM)133.45 ZAX
Annual div yield (TTM)0.45%
Div ex-dateOct 07 2013
Div pay-dateOct 14 2013
Data delayed at least 30 minutes, as of Jul 25 2014 16:49 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Aspen Pharmacare Holdings Ltd+0.16 %-4.75 %+16.53 %+34.13 %+409.06 %
ALL SHARE-0.28 %+2.38 %+10.95 %+26.53 %+115.29 %
ZA/HEALTH CARE+0.39 %+1.13 %+16.19 %+22.61 %--
ZA/PHARMACEUTICALS+0.02 %-4.42 %+14.07 %+25.41 %--
Data delayed at least 30 minutes, as of Jul 25 2014 16:49 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.